Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium
- PMID: 18219257
- DOI: 10.1097/nen.0b013e3181633526
Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium
Abstract
To determine the reliability of assessment of alpha-synuclein-immunoreactive (alphaS-IR) structures by neuropathologists, 28 evaluators from 17 centers of BrainNet Europe examined current methods and reproducibility of alphaS-IR evaluation using a tissue microarray (TMA) technique. Tissue microarray blocks were constructed of samples from the participating centers that contained alphaS-IR structures. Slides from these blocks were stained in each center and assessed for neuronal perikaryal inclusions, neurites, and glial cytoplasmic inclusions. The study was performed in 2 phases. First, the TMA slides were stained with the antibody of the center's choice. In this phase, 59% of the sections were of good or acceptable quality, and 4 of 9 antibodies used performed consistently. Differences in interpretation and categorization of alphaS-IR structures, however, led to differing results between the laboratories. Prior to the second phase, the neuropathologists participated in a training session on the evaluation of alphaS-IR structures. Based on the results of the first phase, selected antibodies using designated antigen retrieval methods were then applied to TMA slides in the second phase. When the designated methods of both staining and evaluation were applied, all 26 subsequently stained TMA sections evaluated were of good/acceptable quality, and a high level of concordance in the assessment of the presence or absence of specific alphaS-IR structures was achieved. A semiquantitative assessment of alphaS-IR neuronal perikaryal inclusions yielded agreements ranging from 49% to 82%, with best concordance in cortical core samples. These results suggest that rigorous methodology and dichotomized assessment (i.e. determining the presence or absence of alphaS-IR) should be applied, and that semiquantitative assessment can be recommended only for the cortical samples. Moreover, the study demonstrates that there are limitations in the scoring of alphaS-IR structures.
Similar articles
-
Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.Acta Neuropathol. 2009 Jun;117(6):635-52. doi: 10.1007/s00401-009-0523-2. Epub 2009 Mar 28. Acta Neuropathol. 2009. PMID: 19330340
-
alpha-Synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85+ study.Acta Neuropathol. 2010 Jun;119(6):715-22. doi: 10.1007/s00401-009-0629-6. Acta Neuropathol. 2010. PMID: 20037761
-
Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment.Exp Neurol. 2002 Jul;176(1):98-104. doi: 10.1006/exnr.2002.7929. Exp Neurol. 2002. PMID: 12093086
-
Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Acta Neuropathol. 2016 Jan;131(1):49-73. doi: 10.1007/s00401-015-1485-1. Epub 2015 Oct 7. Acta Neuropathol. 2016. PMID: 26446103 Free PMC article. Review.
-
Dissecting α-synuclein inclusion pathology diversity in multiple system atrophy: implications for the prion-like transmission hypothesis.Lab Invest. 2019 Jul;99(7):982-992. doi: 10.1038/s41374-019-0198-9. Epub 2019 Feb 8. Lab Invest. 2019. PMID: 30737468 Free PMC article. Review.
Cited by
-
The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.Acta Neuropathol. 2021 Sep;142(3):423-448. doi: 10.1007/s00401-021-02329-9. Epub 2021 Jun 11. Acta Neuropathol. 2021. PMID: 34115198 Free PMC article.
-
Functionally different α-synuclein inclusions yield insight into Parkinson's disease pathology.Sci Rep. 2016 Mar 17;6:23116. doi: 10.1038/srep23116. Sci Rep. 2016. PMID: 26984067 Free PMC article.
-
Clinical phenotypes of Alzheimer's disease: investigating atrophy patterns and their pathological correlates.Alzheimers Res Ther. 2025 Apr 26;17(1):93. doi: 10.1186/s13195-025-01727-5. Alzheimers Res Ther. 2025. PMID: 40281562 Free PMC article.
-
Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging.J Neuropathol Exp Neurol. 2019 Oct 1;78(10):891-899. doi: 10.1093/jnen/nlz080. J Neuropathol Exp Neurol. 2019. PMID: 31504679 Free PMC article.
-
Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains.J Neuropathol Exp Neurol. 2009 Mar;68(3):250-61. doi: 10.1097/NEN.0b013e318198d320. J Neuropathol Exp Neurol. 2009. PMID: 19225411 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical